Clinical Approach to Immunotherapy-induced Type 1 Diabetes Mellitus: A Case of Pembrolizumab Associated Insulin-dependent Diabetes in a Patient with NSCLC
Crossref DOI link: https://doi.org/10.29328/journal.jprr.1001047
Published Online: 2023-09-25
Update policy: https://doi.org/10.29328/crossmark-policy
Ntertsos, Nikolaos
Christantoniou, George
Kyrka, Krystallia
Pezirkianidou, Persefoni
Bikos, Vasileios
Konstantina, Papadaki
Tsiouda, Theodora
License valid from 2023-09-25
